Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Anti-inflammatory effects of methylthiouracil in vitro and in vivo

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2];  [3]
  1. Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, Gyeongsan 712-715 (Korea, Republic of)
  2. Department of Molecular Medicine, CMRI, School of Medicine, Kyungpook National University, Daegu 700-422 (Korea, Republic of)
  3. College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 702-701 (Korea, Republic of)

The screening of bioactive compound libraries can be an effective approach for repositioning FDA-approved drugs or discovering new treatments for human diseases. Here, methylthiouracil (MTU), an antithyroid drug, was examined for its effects on lipopolysaccharide (LPS)-mediated vascular inflammatory responses. The anti-inflammatory activities of MTU were determined by measuring permeability, human neutrophil adhesion and migration, and activation of pro-inflammatory proteins in LPS-activated human umbilical vein endothelial cells and mice. We found that post-treatment with MTU inhibited LPS-induced barrier disruption, expression of cell adhesion molecules (CAMs), and adhesion/transendothelial migration of human neutrophils to human endothelial cells. MTU induced potent inhibition of LPS-induced endothelial cell protein C receptor (EPCR) shedding. It also suppressed LPS-induced hyperpermeability and neutrophil migration in vivo. Furthermore, MTU suppressed the production of tumor necrosis factor-α (TNF-α) and interleukin (IL)-6, and the activation of nuclear factor-κB (NF-κB) and extracellular regulated kinases (ERK) 1/2 by LPS. Moreover, post-treatment with MTU resulted in reduced LPS-induced lethal endotoxemia. These results suggest that MTU exerts anti-inflammatory effects by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases. - Highlights: • MTU reduced LPS-mediated hyperpermeability in vitro and in vivo. • MTU inhibited LPS-mediated leukocyte adhesion and migration. • MTU inhibited LPS-mediated production of IL-6 and TNF-α. • MTU reduced LPS-mediated mortality and lung injury.

OSTI ID:
22687797
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Journal Issue: 3 Vol. 288; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models
Journal Article · Sun Jul 01 00:00:00 EDT 2012 · Toxicology and Applied Pharmacology · OSTI ID:22215351

Vascular barrier protective effects of baicalin, baicalein and wogonin in vitro and in vivo
Journal Article · Fri Nov 14 23:00:00 EST 2014 · Toxicology and Applied Pharmacology · OSTI ID:22439906

Fasudil inhibits neutrophil-endothelial cell interactions by regulating the expressions of GRP78 and BMPR2
Journal Article · Sun Apr 15 00:00:00 EDT 2018 · Experimental Cell Research · OSTI ID:23082415